Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV-16/18

✍ Scribed by A. Szarewski; W.A.J. Poppe; S.R. Skinner; C.M. Wheeler; J. Paavonen; P. Naud; J. Salmeron; S.-N. Chow; D. Apter; H. Kitchener; X. Castellsagué; J.C. Teixeira; J. Hedrick; U. Jaisamrarn; G. Limson; S. Garland; B. Romanowski; F.Y. Aoki; T.F. Schwarz; F.X. Bosch; D.M. Harper; K. Hardt; T. Zahaf; D. Descamps; F. Struyf; M. Lehtinen; G. Dubin; for the HPV PATRICIA Study Group

• Book ID: 112101555
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: French
• Weight: 857 KB
• Volume: 131
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/ijc.26362